Pancreatic Cancer Research

ResearcherGuilin Medical UniversityActive in the last 2 years

Songqing He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8966-2195; OpenAlex author ID A5089884329. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 5

  1. Retraction Note: m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. Co-author DOI 10.1186/s12943-025-02432-5↗
  2. Identification of a novel cuproptosis-related pattern and its tumor microenvironment infiltration characteristics in pancreatic cancer Co-author DOI 10.21203/rs.3.rs-3215150/v1↗
  3. m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. Co-author DOI 10.1186/s12943-019-1128-6↗
  4. MicroRNA-1179 inhibits the proliferation, migration and invasion of human pancreatic cancer cells by targeting E2F5. Last author DOI 10.1016/j.cbi.2018.05.017↗
  5. Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer. Last author DOI 10.1038/srep13563↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fumio Shimamoto · 2 shared papers, 2020–2025 · strength 0.39
  2. Bo Tang · 2 shared papers, 2020–2025 · strength 0.39
  3. Guandou Yuan · 2 shared papers, 2018–2023 · strength 0.28
  4. Guozhen Huang · 1 shared paper, 2023 · strength 0.19
  5. Guoqing Ouyang · 1 shared paper, 2023 · strength 0.19
  6. Chengjie Lin · 1 shared paper, 2018 · strength 0.08
  7. Bo Tang · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.